The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumResearch - Nine Meters Biopharma (NMTR) NMTR has reported top-line Phase 1b/2a data for Short Bowel Syndrome (“SBS”). The gastrointestinal (“GI”) tract is the tract from the mouth to the … Continue Reading
PremiumInsights - Biotech (XBI) had a rough week as investors are moving away from “risky” assets due to the expected rise in interest rates. The XBI ETF, … Continue Reading
PremiumInsights - Novavax (NVAX) had their business update call after market yesterday. The company provided some details on regulatory processes for their Covid vaccine. UK Approval Likely … Continue Reading
PremiumInsights - Essa (EPIX) announced another collaboration for their candidate EPI-7386. The big pharma partner is Astellas and the two companies are testing Astellas/Pfizer enzalutamide (Xtandi) with EPI7386 in … Continue Reading
PremiumInsights - Jounce (JNCE) gave an update during their quarterly call this morning. There were no material changes and their Phase 1 studying ILT4 candidate JTX-8064 in solid tumors … Continue Reading
PremiumInsights - GEN-011 Phase 1 is “Accruing” Patients. Data Q4 2021-Q1 2022Accrued patients have given consent to be part of the trial and are undergoing the procedures … Continue Reading
PremiumInsights - Yesterday, Novavax (NVAX) announced a Memorandum of Understanding (MoU) to supply 1.1 billion doses to COVAX, a worldwide network designed to share access to COVID vaccines globally. … Continue Reading
Premium
